188 related articles for article (PubMed ID: 9232428)
1. Generation of heat shock protein-based vaccines by intracellular loading of gp96 with antigenic peptides.
Heikema A; Agsteribbe E; Wilschut J; Huckriede A
Immunol Lett; 1997 Jun; 57(1-3):69-74. PubMed ID: 9232428
[TBL] [Abstract][Full Text] [Related]
2. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
Vignuzzi M; Gerbaud S; van der Werf S; Escriou N
J Gen Virol; 2001 Jul; 82(Pt 7):1737-1747. PubMed ID: 11413386
[TBL] [Abstract][Full Text] [Related]
3. Induction of MHC class I-restricted CTL response by DNA immunization with ubiquitin-influenza virus nucleoprotein fusion antigens.
Fu TM; Guan L; Friedman A; Ulmer JB; Liu MA; Donnelly JJ
Vaccine; 1998 Nov; 16(18):1711-7. PubMed ID: 9778746
[TBL] [Abstract][Full Text] [Related]
4. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes.
Anderson RW; Bennink JR; Yewdell JW; Maloy WL; Coligan JE
Mol Immunol; 1992 Sep; 29(9):1089-96. PubMed ID: 1495499
[TBL] [Abstract][Full Text] [Related]
5. Induction of cytotoxic T lymphocyte activity by immunization with recombinant Semliki Forest virus: indications for cross-priming.
Huckriede A; Bungener L; Holtrop M; de Vries J; Waarts BL; Daemen T; Wilschut J
Vaccine; 2004 Mar; 22(9-10):1104-13. PubMed ID: 15003637
[TBL] [Abstract][Full Text] [Related]
6. Delivery of a viral antigen to the class I processing and presentation pathway by Listeria monocytogenes.
Ikonomidis G; Paterson Y; Kos FJ; Portnoy DA
J Exp Med; 1994 Dec; 180(6):2209-18. PubMed ID: 7964496
[TBL] [Abstract][Full Text] [Related]
7. Protection against lethal viral infection by vaccination with nonimmunodominant peptides.
Oukka M; Manuguerra JC; Livaditis N; Tourdot S; Riche N; Vergnon I; Cordopatis P; Kosmatopoulos K
J Immunol; 1996 Oct; 157(7):3039-45. PubMed ID: 8816413
[TBL] [Abstract][Full Text] [Related]
8. Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.
Altenburg AF; van de Sandt CE; van Trierum SE; De Gruyter HLM; van Run PRWA; Fouchier RAM; Roose K; Saelens X; Volz A; Sutter G; de Vries RD; Rimmelzwaan GF
J Virol; 2016 Nov; 90(22):10209-10219. PubMed ID: 27581985
[TBL] [Abstract][Full Text] [Related]
9. Isolation of MHC class I-restricted tumor antigen peptide and its precursors associated with heat shock proteins hsp70, hsp90, and gp96.
Ishii T; Udono H; Yamano T; Ohta H; Uenaka A; Ono T; Hizuta A; Tanaka N; Srivastava PK; Nakayama E
J Immunol; 1999 Feb; 162(3):1303-9. PubMed ID: 9973383
[TBL] [Abstract][Full Text] [Related]
10. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
Arnold D; Faath S; Rammensee H; Schild H
J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
[TBL] [Abstract][Full Text] [Related]
11. Presentation by a major histocompatibility complex class I molecule of nucleoprotein peptide expressed in two different genes of an influenza virus transfectant.
Isobe H; Moran T; Li S; Young A; Nathenson S; Palese P; Bona C
J Exp Med; 1995 Jan; 181(1):203-13. PubMed ID: 7528768
[TBL] [Abstract][Full Text] [Related]
12. Comparison of antigen presentation of influenza A nucleoprotein expressed in attenuated AroA- Salmonella typhimurium with that of live virus.
Brett SJ; Rhodes J; Liew FY; Tite JP
J Immunol; 1993 Apr; 150(7):2869-84. PubMed ID: 7681081
[TBL] [Abstract][Full Text] [Related]
13. Targeting heat shock proteins for immunotherapy in multiple myeloma: generation of myeloma-specific CTLs using dendritic cells pulsed with tumor-derived gp96.
Qian J; Wang S; Yang J; Xie J; Lin P; Freeman ME; Yi Q
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8808-15. PubMed ID: 16361569
[TBL] [Abstract][Full Text] [Related]
14. No recognition of MHC class II+ cells infected with a vaccinia virus encoding influenza type A nucleoprotein by class II-restricted T cells.
Freer G; Senesi S
Immunol Lett; 1993 Jun; 36(3):305-12. PubMed ID: 8370602
[TBL] [Abstract][Full Text] [Related]
15. Pretransplant tumor antigen-specific immunization of allogeneic bone marrow transplant donors enhances graft-versus-tumor activity without exacerbation of graft-versus-host disease.
Anderson LD; Mori S; Mann S; Savary CA; Mullen CA
Cancer Res; 2000 Oct; 60(20):5797-802. PubMed ID: 11059776
[TBL] [Abstract][Full Text] [Related]
16. Heat shock protein-peptide complexes for use in vaccines.
Heike M; Noll B; Meyer zum Büschenfelde KH
J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
[TBL] [Abstract][Full Text] [Related]
17. Expression of a viral protein by muscle cells in vivo induces protective cell-mediated immunity.
Ulmer JB; Deck RR; DeWitt CM; Fu TM; Donnelly JJ; Caulfield MJ; Liu MA
Vaccine; 1997 Jun; 15(8):839-41. PubMed ID: 9234528
[TBL] [Abstract][Full Text] [Related]
18. Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells.
Ulmer JB; Deck RR; Dewitt CM; Donnhly JI; Liu MA
Immunology; 1996 Sep; 89(1):59-67. PubMed ID: 8911141
[TBL] [Abstract][Full Text] [Related]
19. Contrasting efficacy of presentation by major histocompatibility complex class I and class II products when peptides are administered within a common protein carrier, self immunoglobulin.
Zaghouani H; Kuzu Y; Kuzu H; Brumeanu TD; Swiggard WJ; Steinman RM; Bona CA
Eur J Immunol; 1993 Nov; 23(11):2746-50. PubMed ID: 8223850
[TBL] [Abstract][Full Text] [Related]
20. Melanoma-reactive class I-restricted cytotoxic T cell clones are stimulated by dendritic cells loaded with synthetic peptides, but fail to respond to dendritic cells pulsed with melanoma-derived heat shock proteins in vitro.
Fleischer K; Schmidt B; Kastenmüller W; Busch DH; Drexler I; Sutter G; Heike M; Peschel C; Bernhard H
J Immunol; 2004 Jan; 172(1):162-9. PubMed ID: 14688322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
